Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, ...

The Studiocanal CEO and Canal+ Deputy CEO on what IPO means for the group, growth ambitions in Africa and beyond & plans for ...

Although any dog can develop health conditions, these breeds are the least likely to have ones that will break the bank.

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in ...

“People in the River are trying to beat the market. In sports betting, the average player loses money because the house takes a cut of every bet. So if you follow the consensus, you’ll eventually go ...

Longevity is increasing worldwide, and Dr Ray O’Connor takes a look at some of the most recent clinical studies on the subject of gerontology ...

It's almost that time of year, the Baftas are coming which means the best of British talent will be celebrated in force come ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...

Several Texas doctors spoke to Courier Texas about how the state’s abortion bans are preventing them from properly providing health care.

Reproductive steroids are powerful hormones that play a key role in the growth and development of our bodies, especially during puberty.